Skip to main content
EMulate Therapeutics, Inc. (EMTX)
EMulate Therapeutics will go public soon, but the exact IPO date is still unknown.
IPO Price Range
$4.00 - $6.00
Shares Offered
2,300,000
Deal Size
$11.50M

EMulate Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20212020
Revenue
0.240.11
Revenue Growth (YoY)
113.27%-
Gross Profit
0.240.11
Selling, General & Admin
10.038.69
Research & Development
1.542.06
Operating Expenses
11.5710.75
Operating Income
-11.33-10.64
Interest Expense / Income
2.991.52
Other Expense / Income
7.77-14.78
Pretax Income
-22.093.46
Net Income
-22.092.62
Net Income Common
-22.093.46
Free Cash Flow
-3.32-4.02
Gross Margin
100.00%100.00%
Operating Margin
-4700.41%-9412.39%
Profit Margin
-9166.80%3059.29%
Free Cash Flow Margin
-1378.42%-3555.75%
EBITDA
-18.064.74
EBITDA Margin
-7491.70%4190.27%
Depreciation & Amortization
1.040.59
EBIT
-19.14.14
EBIT Margin
-7924.90%3664.60%
Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).